Literature DB >> 17392731

Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?

Miroslav M Savić1, Shengming Huang, Roman Furtmüller, Terry Clayton, Sigismund Huck, Dragan I Obradović, Nenad D Ugresić, Werner Sieghart, Dubravko R Bokonjić, James M Cook.   

Abstract

Classical benzodiazepines (BZs) exert anxiolytic, sedative, hypnotic, muscle relaxant, anticonvulsive, and amnesic effects through potentiation of neurotransmission at GABA(A) receptors containing alpha(1), alpha(2), alpha(3) or alpha(5) subunits. Genetic studies suggest that modulation at the alpha(1) subunit contributes to much of the adverse effects of BZs, most notably sedation, ataxia, and amnesia. Hence, BZ site ligands functionally inactive at GABA(A) receptors containing the alpha(1) subunit are considered to be promising leads for novel, anxioselective anxiolytics devoid of sedative properties. In pursuing this approach, we used two-electrode voltage clamp experiments in Xenopus oocytes expressing recombinant GABA(A) receptor subtypes to investigate functional selectivity of three newly synthesized BZ site ligands and also compared their in vivo behavioral profiles. The compounds were functionally selective for alpha(2)-, alpha(3)-, and alpha(5)-containing subtypes of GABA(A) receptors (SH-053-S-CH3 and SH-053-S-CH3-2'F) or essentially selective for alpha(5) subtypes (SH-053-R-CH3). Possible influences on behavioral measures were tested in the elevated plus maze, spontaneous locomotor activity, and rotarod test, which are considered primarily predictive of the anxiolytic, sedative, and ataxic influence of BZs, respectively. The results confirmed the substantially diminished ataxic potential of BZ site agonists devoid of alpha(1) subunit-mediated effects, with preserved anti-anxiety effects at 30 mg/kg of SH-053-S-CH3 and SH-053-S-CH3-2'F. However, all three ligands, dosed at 30 mg/kg, decreased spontaneous locomotor activity, suggesting that sedation may be partly dependent on activity mediated by alpha(5)-containing GABA(A) receptors. Hence, it could be of importance to avoid substantial agonist activity at alpha(5) receptors by candidate anxioselective anxiolytics, if clinical sedation is to be avoided.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392731     DOI: 10.1038/sj.npp.1301403

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  27 in total

Review 1.  GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.

Authors:  Raman Sankar
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

2.  Ester to amide substitution improves selectivity, efficacy and kinetic behavior of a benzodiazepine positive modulator of GABAA receptors containing the α5 subunit.

Authors:  Tamara Timić Stamenić; Michael M Poe; Sabah Rehman; Anja Santrač; Branka Divović; Petra Scholze; Margot Ernst; James M Cook; Miroslav M Savić
Journal:  Eur J Pharmacol       Date:  2016-09-14       Impact factor: 4.432

3.  Further evaluation of the potential anxiolytic activity of imidazo[1,5-a][1,4]diazepin agents selective for α2/3-containing GABAA receptors.

Authors:  J M Witkin; R Cerne; M Wakulchik; J S; S D Gleason; T M Jones; G Li; L A Arnold; J-X Li; J M Schkeryantz; K R Methuku; J M Cook; M M Poe
Journal:  Pharmacol Biochem Behav       Date:  2017-04-22       Impact factor: 3.533

4.  Photopotentiation of the GABAA receptor with caged diazepam.

Authors:  Lorenzo Sansalone; Joshua Bratsch-Prince; Sicheng Tang; Burjor Captain; David D Mott; Françisco M Raymo
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-01       Impact factor: 11.205

5.  GABAA-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vapor.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Drug Alcohol Depend       Date:  2011-09-15       Impact factor: 4.492

Review 6.  GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.

Authors:  Meng-Yi Xu; Albert H C Wong
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

7.  Enhancing the function of alpha5-subunit-containing GABAA receptors promotes action potential firing of neocortical neurons during up-states.

Authors:  Berthold Drexler; Stefan Zinser; Shengming Huang; Michael M Poe; Uwe Rudolph; James M Cook; Bernd Antkowiak
Journal:  Eur J Pharmacol       Date:  2013-02-01       Impact factor: 4.432

8.  Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats?

Authors:  Miroslav M Savić; Samarpan Majumder; Shengming Huang; Rahul V Edwankar; Roman Furtmüller; Srdan Joksimović; Terry Clayton; Joachim Ramerstorfer; Marija M Milinković; Bryan L Roth; Werner Sieghart; James M Cook
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-01-13       Impact factor: 5.067

9.  Glutamatergic and GABAergic modulations of ultrasonic vocalizations during maternal separation distress in mouse pups.

Authors:  Aki Takahashi; Jasmine J Yap; Dawnya Zitzman Bohager; Sara Faccidomo; Terry Clayton; James M Cook; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2008-12-20       Impact factor: 4.530

10.  The differential role of alpha1- and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats.

Authors:  Miroslav M Savić; Marija M Milinković; Sundari Rallapalli; Terry Clayton; Sroan Joksimović; Michael Van Linn; James M Cook
Journal:  Int J Neuropsychopharmacol       Date:  2009-03-06       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.